SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-010086
Filing Date
2021-09-14
Accepted
2021-09-14 17:27:54
Documents
15
Period of Report
2021-09-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT pbsv_8k.htm   iXBRL 8-K 19321
2 PRESS RELEASE pbsv_ex991.htm EX-99.1 7138
  Complete submission text file 0001654954-21-010086.txt   139395

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbsv-20210914.xsd EX-101.SCH 5595
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbsv-20210914_cal.xml EX-101.CAL 890
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbsv-20210914_def.xml EX-101.DEF 2097
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbsv-20210914_lab.xml EX-101.LAB 12680
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbsv-20210914_pre.xml EX-101.PRE 7969
8 EXTRACTED XBRL INSTANCE DOCUMENT pbsv_8k_htm.xml XML 3140
Mailing Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646
Business Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646 787-278-2709
Pharma-Bio Serv, Inc. (Filer) CIK: 0001304161 (see all company filings)

IRS No.: 200653570 | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-50956 | Film No.: 211253281
SIC: 8742 Services-Management Consulting Services
Office of Trade & Services